Antiplatelet use: secondary prevention for ischemic stroke with a history of intracranial hemorrhage
10.3760/cma.j.issn.1006-7876.2010.12.004
- VernacularTitle:伴脑出血史的缺血性卒中患者使用抗血小板药物二级预防的调查
- Author:
Weihua JIA
;
Lichun ZHOU
- Publication Type:Journal Article
- Keywords:
Brain ischemia;
Stroke;
Platelet aggregation inhibitors
- From:
Chinese Journal of Neurology
2010;43(12):828-831
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the usage of antiplatelet drugs(APD)therapy in ischemic stroke with a history of intracranial hemorrhage(ICH)and impact of APD therapy in recurrences of the ICH and the ischemic stroke. Methods In a retrospective study, all survivors of ischemic stroke with ICH who visited our hospital previous to this study were followed by clinic visit or by telephone interview and recurrent ICH, ischemic stroke, and APD use were recorded. Kaplan-Meier plot and Logistic regression were used to assess the effect of APD on recurrent ICH and isclemic stroke. Results Recurrent ICH was more common in patients with lobar hemorrhage compared than patients with deep hemorrhage. APD use was more common for prevention of myocardial infarction and atrial fibrillation. APD use did not increase ICH recurrence (OR = 1. 149, 95% CI 0. 376-3.513, P=0.808)and did not shorten duration of ICH recurrence(X2=1.257, P=0.262); however, it did reduce ischemic stroke recurrence(OR=0.410, 95% CI0. 203-0.826, P=0.013)and prolonged duration(X2 =14.315, P=0.001). Conclusion APD use was not associated with ICH recurrence and was beneficial to recurrence ischemic stroke in this observation study.
